A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer
Status:
NOT_YET_RECRUITING
Trial end date:
2026-11-21
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, multicenter, phase Ⅲ clinical study to compare the clinical efficacy and safety of Docetaxel for Injection (Albumin Bound) in combination with best supportive care versus placebo in combination with best supportive care in participants with pancreatic cancer who have received gemcitabine-containing and fluorouracil-containing regimens.